DISCOUNT ZERTIFIKAT - BIOGEN IDEC | Delayed Deutsche Boerse AG 10:52:51 2024-06-26 EDT | ||
| 209 EUR | +0.23% |
|
| Current month | +1.74% | ||
| 1 month | +4.54% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 209 | +0.23% |
| 24-06-25 | 208.5 | -1.14% |
| 24-06-24 | 210.9 | +1.10% |
| 24-06-21 | 208.6 | -0.84% |
| 24-06-20 | 210.4 | +1.74% |
Delayed Quote Deutsche Boerse AG
Last update June 26, 2024 at 10:52 am
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM5US5 |
| ISIN | DE000VM5US54 |
| Date issued | 2023-11-22 |
| Maturity | 2024-09-20 (86 Days) |
| Parity | 1 : 1 |
| Emission price | 203.3 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 219.6 € |
|---|---|
| Lowest since issue | 178.5 € |
| Spread | 0.22 € |
| Spread % | 0.10% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
223.2
USD
Average target price
283.2
USD
Spread / Average Target
+26.87%
- Stock Market
- Certificates
- Certificat
